Simple Summary Pancreatic cancer is difficult to treat. Novel treatment strategies are urgently needed to improve the survival rate, which is approximately 10% five years after …
X Li, Q Li, B Xiong, H Chen, X Wang, D Zhang - Pharmacological Research, 2022 - Elsevier
Background and aims Discoidin domain receptor 1 (DDR1) encodes a receptor tyrosine kinase involved in multiple physiological and pathological processes. DDR1 is expressed in …
Y Wu, C Zhang, M Guo, W Hu, Y Qiu, M Li… - Frontiers in …, 2022 - frontiersin.org
Chronic pancreatitis (CP) is a precancerous illness linked to pancreatic ductal adenocarcinoma (PDAC), although the evolutionary mechanism is uncertain. CP is …
F Kong, Y Pan, D Wu - Biomedicines, 2024 - mdpi.com
In the complex progression of fibrosis in chronic pancreatitis, pancreatic stellate cells (PSCs) emerge as central figures. These cells, initially in a dormant state characterized by the …
CM Borza, G Bolas, A Pozzi - Frontiers in Pharmacology, 2022 - frontiersin.org
Following injury the kidney undergoes a repair process, which results in replacement of the injured tissue with little evidence of damage. However, repetitive injuries or inability of the …
X Li, H Chen, D Zhang - Journal of Clinical Pharmacy and …, 2022 - Wiley Online Library
What is known and objective Discoidin domain receptor 1 (DDR1) is a receptor tyrosine kinase involved in the pathological processes of several diseases, such as keloid formation …
S Bibi, W Zeng, P Zheng, SMM Mehmandousti, T Jin - hLife, 2024 - Elsevier
Despite significant discoveries in basic cancer research and improvements in treatment options and clinical outcomes, cancer remains a major public health concern worldwide …